Smoking-related lung diseases: A clinical perspective

European Respiratory Journal

Volumn 35, Issue 2, 2010, Pages 231-233

  Balbi, B ^a   Cottin, V ^b   Singh, S ^c   De Wever, W ^d   Herth, F J F ^e   Robalo Cordeiro, C ^f  

^a IRCCS   (Italy)

^b UNIVERSITÉ LYON 1   (France)

^c GLENFIELD HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CIGARETTE SMOKING; DISEASE ASSOCIATION; EDITORIAL; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS X; INTERSTITIAL LUNG DISEASE; LUNG CANCER; LUNG DISEASE; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG RESECTION; PRIORITY JOURNAL; PULMONARY REHABILITATION; SMOKING; STENT;

EMPHYSEMA; EVIDENCE-BASED MEDICINE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; PULMONARY MEDICINE; SMOKING; TREATMENT OUTCOME;

EID: 76149105846     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00189309     Document Type: Editorial

References (22)

1. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8: 1398-1420.
2. Cosio Piqueras MG, Cosio MG. Disease of the airways in chronic obstructive pulmonary disease. Eur Respir J 2001; 18: Suppl. 34, 41s-49s.
3. Takahashi M, Fukuoka J, Nitta N, et al. Imaging of pulmonary emphysema: a pictorial review. Int J Chron Obstruct Pulmon Dis 2008; 3: 193-204.
4. Seersholm, Wencker M, Banik N, et al. Does a1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary a1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) a1-AT study group. Eur Respir J 1997; 10: 2260-2263.
5. ATS/ERS Statement. Standards for diagnosis and management of individuals with a1-antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900.
6. Strange C, Herth FJ, Kovitz KL, et al. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med 2007; 7: 10.
7. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society Statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
8. Holland AE, McDonald CF. Pulmonary rehabilitation and interstitial lung disease. Thorax 2009; 64: 548.
9. Carone M, Patessio A, Ambrosino N, et al. Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. Respir Med 2007; 101: 2447-2453.
10. Evans RA, Singh SJ, Collier R. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med 2009; 103: 1070-1075.
11. Watz H, Waschki B, Meyer T. Physical activity in patients with COPD. Eur Respir J 2009; 33: 262-272.
12. American Cancer Society. Cancer Facts and Figures, 2008. Atlanta, American Cancer Society, 2008. Available from http://www. cancer.org/docroot/ STT/content/STT-1x-Cancer-Facts-and-Figures-2008.asp.
13. Bolliger CT, Sutedja TG, Strausz J, et al. Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur Respir J 2006; 27: 1258-1271.
14. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-593.
15. Cottin V, Fabien N, Khouatra C, et al. Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema. Eur Respir J 2009; 33: 219-221.
16. Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105-111.
17. Mejia M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10-15.
18. Cordeiro CR, Freitas S, Rodrigues B, et al. Diagnosis of respiratory bronchiolitis associated interstitial lung disease. Monaldi Arch Chest Dis 2006; 2: 96-101.
19. Ryu JH, Colby TV, Hartman TE, et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001; 17: 122-132.
20. Vassalo R, Ryu JH. Tobacco smoke-related diffuse lung diseases. Semin Respir Crit Care Med 2008; 29: 643-650.
21. Vassalo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary langerhans cell histiocytosis: high resolution CT, histologic and functional correlations. Chest 2003; 124: 1199-1205.
22. Shorr AF, Scoville SL, Cersovsky SB, et al. Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA 2004; 292: 2997-3005.